NCT00506298View on ClinicalTrials.gov

Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions

Type 2 Diabetes

Interventions

DRUG

bezafibrate + diflunisal

bezafibrate + diflunisal

DRUG

bezafibrate + placebo

bezafibrate + placebo

Trial Locations (18)

Unknown

Chilliwack

Vancouver

Winnipeg

Bay Roberts

Holyroad

St. John's

Aylmer

Burlington

Collingwood

Corunna

Greater Sudbury

Robarts Research Institute, London

London

Newmarket

Sarnia

Toronto

Montreal

Saskatoon

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Zalicus

INDUSTRY

NCT00506298 - Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes | Biotech Hunter | Biotech Hunter